JSPR Jasper Therapeutics Inc

P/E --
Forward P/E --
Price/Sales --
Beta 3.029
Div Yield --
Market Cap --

Company Analysis

Latest News

🔴 Jasper Therapeutics is trading 10.68% down today as U.S.-Iran clashes fuel risk aversion

Jasper Therapeutics is trading at $0.64 (-10.68%) amid renewed U.S.-Iran clashes, rising oil prices, and broader risk aversion. - Biotech shares are under...

🔴 Jasper Therapeutics is trading 5.48% down today amid renewed U.S.-Iran clashes

Jasper Therapeutics is trading at $0.67 (-5.48%) after renewed U.S.-Iran clashes intensified global risk-off sentiment and pushed oil prices higher. - The...

🔴 Jasper Therapeutics is trading 8.63% down in pre-market as renewed U.S.-Iran clashes intensify global risk-off sentiment

Jasper Therapeutics is trading 8.63% down at $0.65 in pre-market after renewed U.S.-Iran clashes intensified global risk-off sentiment. - Reuters reported oil...

🔴 Jasper Therapeutics is trading 5.4% down today amid renewed U.S.-Iran clashes

Jasper Therapeutics is trading at $0.66 (-5.39%) amid broad risk-off trading following renewed U.S.-Iran clashes. - No new company-specific announcement or...

🔴 Jasper Therapeutics falls 5.5% — Biotech Sector Declines Amid Fed Rate Hike Fears

With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...

Jasper Therapeutics Receives Nasdaq Non-Compliance Notice Over Listing Rule

Jasper Therapeutics, Inc. (JSPR) announced it received a notice from The Nasdaq Stock Market on August 21, 2026, indicating the company is not in compliance...

Jasper Therapeutics proposes reverse split, fighting to keep Nasdaq listing

Jasper Therapeutics scheduled a special stockholder meeting for September 30, 2026. Investors will vote on a proposed reverse stock split. The board seeks...

Jasper Therapeutics second quarter 2026 net loss narrows to $2.8M amid Kira acquisition and $132M financing

Jasper Therapeutics reported a net loss of $2.8 million for the second quarter 2026, a significant reduction from the $26.7 million loss in the prior-year...